首页> 外文期刊>Toxicology Research >Quantitative proteomic analysis of HeLa cells in response to biocompatible Fe2C@C nanoparticles: O-16/O-18-labelling & HPLC-ESI-orbit-trap profiling approach
【24h】

Quantitative proteomic analysis of HeLa cells in response to biocompatible Fe2C@C nanoparticles: O-16/O-18-labelling & HPLC-ESI-orbit-trap profiling approach

机译:响应生物相容性Fe2C + C纳米粒子的定量蛋白质组学分析,αcαc:O-16 / O-18标记& HPLC-ESI轨道 - 陷阱分析方法

获取原文
获取原文并翻译 | 示例
           

摘要

The effective detection of molecular biomarkers, such as proteins, lipids, carbohydrates, and pathogens, in a living body is a huge challenge in the field of nanomedicine. Here, we have investigated the comparative quantitative proteomics analysis of the molecular response of HeLa cells to biocompatible Fe2C@ C nanoparticles (NPs) using O-16/O-18 isotopic labelling of the cell culture. The relative binding efficiency of proteins to Fe2C@ C NPs was calculated. HPLC-ESI-orbit-trap analysis found 51 differentially expressed proteins, out of which 23 were over-expressed and 28 down-regulated. This study showed that Fe2C@ C NPs alter the expression of the proteins involved in endocytosis, cell-cycle regulation, and cell membrane protrusion. Further, the quantification and validation of the mass spectrometry (MS) results was successfully confirmed by western blot analysis of cytochrome C. The change in the expression of proteins can be useful for early stage disease diagnoses and the development of tailored therapeutic strategies. This study is the first large-scale characterization of low abundance proteins on Fe2C@ C NPs, providing the biochemical basis for the assessment of the suitability of magnetic NPs as biomedical markers and emerging functional probes.
机译:在生物体内有效地检测分子生物标志物,例如蛋白质,脂质,碳水化合物和病原体是纳米医生领域的巨大挑战。在这里,我们研究了使用细胞培养物的O-16 / O-18同位素标记对生物相容性Fe2C @ C纳米颗粒(NPS)的对比定量蛋白质组学分析。计算蛋白质对Fe2C @ C NP的相对结合效率。 HPLC-ESI-ORBIT-TAP分析发现51个差异表达的蛋白质,其中23个被过度表达和28个下调。该研究表明,Fe2C @ C NPS改变了引起内吞作用,细胞循环调节和细胞膜突起所涉及的蛋白质的表达。此外,通过对细胞色素C的蛋白质印迹分析成功证实了质谱(MS)结果的定量和验证。蛋白质表达的变化可用于早期疾病诊断和量身定制的治疗策略的发展。该研究是Fe2C @ C NPS上低丰度蛋白的第一种大规模表征,为评估磁NPS作为生物医学标志物和新兴功能探测的评估提供生化基础。

著录项

  • 来源
    《Toxicology Research》 |2018年第1期|共9页
  • 作者单位

    Islamia Univ Bahawalpur Dept Biochem &

    Biotechnol Bahawalpur Pakistan;

    Quaid I Azam Univ Dept Plant Sci Islamabad 45320 Pakistan;

    Shenzhen Univ Coll Life Sci Shenzhen 10590 Peoples R China;

    Islamia Univ Bahawalpur Dept Biochem &

    Biotechnol Bahawalpur Pakistan;

    RMIT Univ Sch Engn 124 La Trobe St Melbourne Vic 3001 Australia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号